What is the recommended approach and work‑up for a patient with decompensated chronic liver disease (DCLD) presenting with ascites?

Approach and Work-up for DCLD with Ascites

Every patient with decompensated chronic liver disease presenting with ascites requires immediate diagnostic paracentesis to rule out spontaneous bacterial peritonitis (SBP), regardless of whether infection symptoms are present 1.

Initial Diagnostic Paracentesis

Perform diagnostic paracentesis emergently in all hospitalized patients with ascites, even without infection symptoms 1. This is the cornerstone of your initial work-up and should be done before any other interventions.

Paracentesis Technique and Testing

• Bedside inoculation: Immediately inoculate at least 10 mL of ascitic fluid into aerobic and anaerobic blood culture bottles at the bedside (increases culture sensitivity to >90%) 1
• Timing: Obtain cultures BEFORE administering any antibiotics 1
• Cell count with differential: PMN count >250/mm³ establishes SBP diagnosis 1
• Simultaneous blood cultures: Draw blood cultures concurrently to increase organism isolation rates 1

When to Perform Paracentesis

• All emergency hospital admissions with ascites 1
• Any signs/symptoms/laboratory abnormalities suggesting infection 1
• Tense ascites with acute kidney injury (AKI) 1
• If paracentesis is negative but pleural effusion present with suspected infection, perform diagnostic thoracentesis 1

Grading Ascites and Initial Management Strategy

Grade 2 (Moderate) Ascites - First Episode

Start with spironolactone (anti-mineralocorticoid) monotherapy at 100 mg/day 2:

• Increase stepwise every 72 hours (in 100 mg increments) up to maximum 400 mg/day if no response 2
• Target weight loss: 0.5 kg/day without edema, 1 kg/day with edema 2
• Add furosemide 40 mg/day if weight reduction <2 kg/week or hyperkalemia develops 2
• Increase furosemide stepwise (40 mg increments) to maximum 160 mg/day 2

Grade 2 (Moderate) Ascites - Recurrent or Long-standing

Start combination therapy immediately: spironolactone plus furosemide, with sequential dose increases based on response 2

Grade 3 (Large/Tense) Ascites

Large volume paracentesis (LVP) is the treatment of choice 2:

• Perform under strict sterile conditions
• Safe even with INR >1.5 and platelets <50,000/mm³ 2

Critical Monitoring During Diuretic Therapy

Frequent clinical and biochemical monitoring is mandatory, especially during the first month 2:

Monitor These Parameters Serially:

• Serum creatinine
• Serum sodium
• Serum potassium
• Body weight
• Urine sodium (in non-responders to identify excessive sodium intake) 2

When to Stop or Adjust Diuretics

Discontinue diuretics immediately if 2:

• Severe hyponatremia (sodium <125 mmol/L, though some experts use 120 mmol/L threshold)
• Acute kidney injury develops
• Worsening hepatic encephalopathy
• Incapacitating muscle cramps

Stop furosemide specifically if severe hypokalemia occurs (<3 mmol/L) 2

Stop spironolactone specifically if severe hyperkalemia occurs (>6 mmol/L) 2

Managing Diuretic-Related Complications

Muscle Cramps

Albumin infusion or baclofen (start 10 mg/day, increase weekly by 10 mg/day up to 30 mg/day) 2

Hyponatremia

• Temporarily withdraw diuretics when sodium drops below 120-125 mmol/L 2
• Occurs more commonly with loop diuretics due to inhibition of solute-free water generation 2

Pre-Treatment Corrections Required

Before initiating diuretic therapy, correct 2:

• GI hemorrhage
• Renal impairment
• Hepatic encephalopathy
• Hyponatremia
• Potassium abnormalities

Use cautious initiation with frequent monitoring in these patients 2. Diuretics are generally not recommended in persistent overt hepatic encephalopathy 2.

Antibiotic Management for SBP

Start IV antibiotics empirically (before culture results) when ascites PMN count >250/mm³ 1:

First-Line Therapy (Community-Acquired, Low MDRO Risk)

• IV cefotaxime 2 g every 12 hours or ceftriaxone 1
• Resolution rates ~90% in settings without prevalent multidrug-resistant organisms (MDROs) 1

High MDRO Risk Settings

Use broader-spectrum antibiotics in 1:

• Nosocomial infections
• Recent hospitalization
• Critically ill/ICU patients
• Healthcare-associated SBP

Common Organisms

• 60% gram-negative (E. coli most common, then Klebsiella pneumoniae) 1
• Increasing shift toward gram-positive and MDROs (35% of overall infections) 1
• Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium 1
• Fungi <5% 1

Critical Pitfalls to Avoid

1. Never delay paracentesis waiting for coagulation correction—it's safe even with coagulopathy 2
2. Never start antibiotics before obtaining ascitic fluid cultures—this dramatically reduces organism isolation 1
3. Don't place chest tubes for spontaneous bacterial empyema (SBE)—despite the term "empyema," these patients should NOT be drained 1
4. Distinguish SBP from secondary peritonitis: Patients with focal intra-abdominal processes (diverticulitis, cholecystitis) may have PMN >250/mm³ but require treatment of the underlying condition, not SBP protocols 1
5. Don't continue diuretics during severe complications—temporary withdrawal is safer than pushing through 2

Dose Reduction After Response

Once ascites largely resolves, reduce diuretics to the lowest effective maintenance dose 2. This minimizes side effects while preventing recurrence.